Hahn Mark W
Insider CIK 1408502 · CEMP EVP and CFO · SLNO Director · VRNA Chief Financial Officer · DOVA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLNO SOLENO THERAPEUTICS INC | D To issuer | 2026-05-18 | 2026-05-18 | 10,046 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2025-10-13 | 2025-10-14 | 10,046 | — | $0 | 10,046 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 445,536 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-10-07 | 2025-10-08 | 1,649,952 | — | $0 | 1,649,952 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 1,649,952 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 389,792 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 800,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-10-07 | 2025-10-08 | 3,285,280 | — | $0 | 3,285,280 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 3,285,280 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 11,264,968 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | G Gift | 2025-08-29 | 2025-09-03 | 1,200,000 | — | $0 | 11,264,968 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-08-01 | 2025-08-05 | 200,000 | — | $0 | 800,000 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-08-01 | 2025-08-05 | 55,696 | — | $0 | 389,792 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-08-01 | 2025-08-05 | 255,696 | — | $0 | 12,673,880 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-08-01 | 2025-08-05 | 208,912 | $13.14 | $2.75M | 12,464,968 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2025-07-08 | 2025-07-09 | 90,320 | $11.44 | $1.03M | 12,418,184 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-07-07 | 2025-07-09 | 229,512 | — | $0 | 445,536 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-07-07 | 2025-07-09 | 675,048 | — | $0 | 675,048 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-07-07 | 2025-07-09 | 229,512 | — | $0 | 12,508,504 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-06-11 | 2025-06-13 | 400,000 | $11.40 | $4.56M | 12,278,992 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-29 | 2025-05-29 | 204,864 | $9.33 | $1.91M | 12,678,992 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-28 | 2025-05-29 | 162,704 | $9.30 | $1.51M | 12,883,856 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-27 | 2025-05-29 | 32,432 | $9.53 | $309.1K | 13,046,560 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-02 | 2025-05-05 | 400,000 | $9.09 | $3.64M | 13,078,992 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-05-01 | 2025-05-05 | 200,000 | — | $0 | 1,000,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-01 | 2025-05-05 | 108,272 | $8.95 | $969.0K | 13,357,728 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-01 | 2025-05-05 | 78,736 | $8.95 | $704.7K | 13,478,992 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-05-01 | 2025-05-05 | 200,000 | — | $0 | 13,557,728 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-04-29 | 2025-05-01 | 229,512 | — | $0 | 445,488 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-04-29 | 2025-05-01 | 675,000 | — | $0 | 675,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-04-29 | 2025-05-01 | 90,360 | $8.98 | $811.4K | 13,466,000 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-04-29 | 2025-05-01 | 229,512 | — | $0 | 13,556,360 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2025-02-03 | 2025-02-04 | 166,888 | $7.16 | $1.19M | 13,326,848 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2025-02-01 | 2025-02-04 | 200,000 | — | $0 | 13,493,736 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-12-06 | 2024-12-06 | 183,728 | $5.01 | $920.5K | 13,293,736 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-12-05 | 2024-12-06 | 640,048 | $5.01 | $3.21M | 13,477,464 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-12-04 | 2024-12-06 | 58,184 | $5.00 | $290.9K | 14,117,512 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-12-02 | 2024-12-02 | 1,600 | $5.00 | $8.0K | 14,175,696 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-11-29 | 2024-12-02 | 98,704 | $5.01 | $494.5K | 14,177,296 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-11-27 | 2024-12-02 | 12,936 | $5.00 | $64.7K | 14,276,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-11-26 | 2024-11-26 | 800 | $5.00 | $4.0K | 14,288,936 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-11-25 | 2024-11-26 | 1,600 | $5.00 | $8.0K | 14,289,736 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-11-11 | 2024-11-13 | 2,400 | $5.00 | $12.0K | 14,291,336 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-11-04 | 2024-11-05 | 80,784 | $4.39 | $354.6K | 14,293,736 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2024-11-01 | 2024-11-01 | 200,000 | — | $0 | 14,669,360 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-11-01 | 2024-11-01 | 245,952 | $4.24 | $1.04M | 14,423,408 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-11-01 | 2024-11-05 | 48,888 | $4.38 | $214.1K | 14,374,520 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2024-10-30 | 2024-11-01 | 800,000 | — | $0 | 14,469,360 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-10-25 | 2024-10-25 | 3,200 | $4.38 | $14.0K | 13,669,360 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-10-24 | 2024-10-25 | 141,360 | $4.38 | $619.2K | 13,672,560 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-10-22 | 2024-10-22 | 159,344 | $4.38 | $697.9K | 13,813,920 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-10-21 | 2024-10-22 | 116,696 | $4.38 | $511.1K | 13,973,264 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-10-18 | 2024-10-22 | 249,728 | $4.38 | $1.09M | 14,089,960 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-09-11 | 2024-09-13 | 600,000 | $3.76 | $2.26M | 14,339,688 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-08-13 | 2024-08-14 | 3,736 | $3.25 | $12.1K | 14,939,688 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-08-13 | 2024-08-14 | 394,664 | $3.20 | $1.26M | 14,943,424 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2024-08-12 | 2024-08-14 | 1,600 | $3.13 | $5.0K | 15,338,088 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2024-08-07 | 2025-05-01 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-08-07 | 2024-08-09 | 314,800 | $2.62 | $824.8K | 15,339,688 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2024-08-07 | 2024-08-09 | 800,000 | — | $0 | 15,654,488 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-08-01 | 2024-08-05 | 88,544 | $2.83 | $250.6K | 14,854,488 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-05-01 | 2024-05-03 | 88,544 | $1.93 | $170.9K | 14,943,032 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2024-02-01 | 2024-02-05 | 480,664 | $2.29 | $1.10M | 15,031,576 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2023-11-01 | 2023-11-03 | 809,008 | $1.74 | $1.41M | 15,512,240 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2023-10-20 | 2023-10-24 | 800,000 | — | $0 | 16,321,248 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-07 | 2023-08-07 | 8,616 | $2.47 | $21.3K | 15,521,248 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-04 | 2023-08-07 | 150,000 | $2.50 | $375.0K | 15,529,864 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-03 | 2023-08-07 | 117,272 | $2.54 | $297.9K | 15,679,864 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-02 | 2023-08-03 | 73,704 | $2.59 | $190.9K | 15,797,136 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-08-01 | 2023-08-03 | 105,944 | $2.68 | $283.9K | 15,870,840 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-05-01 | 2023-05-03 | 455,528 | $2.58 | $1.18M | 15,976,784 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2023-02-01 | 2023-02-03 | 413,168 | $2.56 | $1.06M | 16,432,312 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-12-20 | 2022-12-21 | 600,000 | $2.12 | $1.27M | 16,845,480 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-11-01 | 2022-11-03 | 13,160 | $1.67 | $22.0K | 17,445,480 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2022-11-01 | 2022-11-03 | 454,856 | $1.60 | $727.8K | 17,458,640 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2022-09-26 | 2022-09-28 | 3,600,000 | — | $0 | 17,913,496 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-08-09 | 2022-08-11 | 600,000 | $1.75 | $1.05M | 14,313,496 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2022-08-01 | 2022-08-03 | 454,856 | $0.67 | $304.8K | 14,926,664 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-08-01 | 2022-08-03 | 13,168 | $0.70 | $9.2K | 14,913,496 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-05-03 | 2022-05-05 | 12,512 | $0.50 | $6.3K | 15,381,520 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2022-05-01 | 2022-05-03 | 432,128 | $0.52 | $224.7K | 15,394,032 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2022-02-02 | 2022-02-03 | 10,416 | $0.76 | $7.9K | 15,826,160 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2022-02-01 | 2022-02-03 | 133,776 | $0.75 | $100.3K | 16,124,896 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2022-02-01 | 2022-02-03 | 288,320 | $0.78 | $224.9K | 15,836,576 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2021-11-02 | 2021-11-03 | 10,416 | $0.65 | $6.8K | 15,991,120 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2021-11-01 | 2021-11-03 | 454,848 | $0.64 | $291.1K | 16,001,536 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2021-08-02 | 2021-08-03 | 10,416 | $0.77 | $8.0K | 16,456,384 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2021-08-01 | 2021-08-03 | 454,840 | $0.79 | $359.3K | 16,466,800 | SEC↗ |
| VRNA Verona Pharma plc | F Tax w/h | 2021-05-03 | 2021-05-05 | 2,122,448 | $0.89 | $1.89M | 16,932,056 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2021-05-03 | 2021-05-05 | 10,416 | $0.87 | $9.1K | 16,921,640 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2021-03-01 | 2021-03-03 | 26,728 | $1.14 | $30.5K | 19,054,504 | SEC↗ |
| VRNA Verona Pharma plc | A Award | 2021-01-28 | 2021-02-01 | 105,824 | — | $0 | 19,081,232 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer deriv | 2019-11-12 | 2019-11-12 | 250,000 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer deriv | 2019-11-12 | 2019-11-12 | 50,000 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer | 2019-11-12 | 2019-11-12 | 9,024 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-09-30 | 2019-10-02 | 775 | $28.00 | $21.7K | 9,024 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-07-01 | 2019-07-02 | 1,545 | $14.17 | $21.9K | 9,799 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award deriv | 2019-01-04 | 2019-01-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award | 2019-01-04 | 2019-01-08 | 8,844 | — | $0 | 11,344 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | P Buy | 2018-12-19 | 2018-12-21 | 2,500 | $6.28 | $15.7K | 2,500 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award deriv | 2018-10-08 | 2018-10-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | A Award deriv | 2018-01-31 | 2018-02-01 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2017-02-23 | 2017-02-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2017-01-03 | 2017-01-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2016-01-01 | 2016-01-05 | 59,660 | — | $0 | 59,660 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2015-01-01 | 2015-01-02 | 46,363 | — | $0 | 46,363 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2014-01-08 | 2014-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2014-01-08 | 2014-01-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2013-01-18 | 2013-01-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2012-03-20 | 2012-03-22 | 25,000 | — | $0 | 25,000 | SEC↗ |